Article

Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.

Kamakura Research Laboratories, Chugai Pharmaceutical Co. Ltd., 200-Kajiwara, Kamakura, Kanagawa 247-8530, Japan.
Bioorganic & medicinal chemistry letters (impact factor: 2.65). 03/2009; 19(6):1753-7. DOI:10.1016/j.bmcl.2009.01.074
Source: PubMed

ABSTRACT A series of benzofuran-based farnesyltransferase inhibitors have been designed and synthesized as antitumor agents. Among them, 11f showed the most potent enzyme inhibitory activity (IC(50)=1.1nM) and antitumor activity in human cancer xenografts in mice.

0 0
 · 
0 Bookmarks
 · 
50 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

antitumor activity
 
antitumor agents
 
benzofuran-based farnesyltransferase inhibitors
 
human cancer xenografts
 
potent enzyme inhibitory activity
 

Kohsuke Asoh